Evidence map›Paper›PMID 21712383›Full record

ArticleThe Journal of biological chemistry2011

Spectrin-like repeats 11-15 of human dystrophin show adaptations to a lipidic environment.

Joe Sarkis, Jean-François Hubert, Baptiste Legrand, Estelle Robert, Angélique Chéron, Julien Jardin, Eric Hitti, Elisabeth Le Rumeur, Véronique Vié

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Joe SarkisUniversité Européenne de Bretagne, 35000 Rennes, France; UMR-CNRS 6026-IFR 140, Equipe RMN-Interactions Lipides Protéines, Faculté de Médecine, CS 34317, 35043 Rennes, France; UMR-CNRS 6251, Institut de Physique de Rennes, Université de Rennes 1, 35042 Rennes, France.
Jean-François HubertUniversité Européenne de Bretagne, 35000 Rennes, France; UMR-CNRS 6026-IFR 140, Equipe RMN-Interactions Lipides Protéines, Faculté de Médecine, CS 34317, 35043 Rennes, France.
Baptiste LegrandUniversité Européenne de Bretagne, 35000 Rennes, France; UMR-CNRS 6026-IFR 140, Equipe RMN-Interactions Lipides Protéines, Faculté de Médecine, CS 34317, 35043 Rennes, France.
Estelle RobertUniversité Européenne de Bretagne, 35000 Rennes, France; UMR-CNRS 6251, Institut de Physique de Rennes, Université de Rennes 1, 35042 Rennes, France.
Angélique ChéronUniversité Européenne de Bretagne, 35000 Rennes, France; UMR-CNRS 6026-IFR 140, Equipe RMN-Interactions Lipides Protéines, Faculté de Médecine, CS 34317, 35043 Rennes, France.
Julien JardinUniversité Européenne de Bretagne, 35000 Rennes, France; Institut National de la Recherche Agronomique (INRA), AGROCAMPUS-OUEST, UMR 1253, Science et Technologie du Lait et de l'Oeuf, 35042 Rennes, France.
Eric HittiUniversité Européenne de Bretagne, 35000 Rennes, France; Laboratoire Traitement du Signal et de l'Image (LTSI), INSERM 642, 35042 Rennes, France.
Elisabeth Le RumeurUniversité Européenne de Bretagne, 35000 Rennes, France; UMR-CNRS 6026-IFR 140, Equipe RMN-Interactions Lipides Protéines, Faculté de Médecine, CS 34317, 35043 Rennes, France.
Véronique ViéUniversité Européenne de Bretagne, 35000 Rennes, France; UMR-CNRS 6251, Institut de Physique de Rennes, Université de Rennes 1, 35042 Rennes, France. Electronic address: veronique.vie@univ-rennes1.fr.
Centre National de la Recherche Scientifique · FRUniversité Européenne de Bretagne · FRInserm · FRInstitut Agro Rennes-Angers · FRInstitut de Physique de Rennes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dystrophin is essential to skeletal muscle function and confers resistance to the sarcolemma by interacting with cytoskeleton and membrane. In the present work, we characterized the behavior of dystrophin 11-15 (DYS R11-15), five spectrin-like repeats from the central domain of human dystrophin, with lipids. DYS R11-15 displays an amphiphilic character at the liquid/air interface while maintaining its secondary α-helical structure. The interaction of DYS R11-15 with small unilamellar vesicles (SUVs) depends on the lipid nature, which is not the case with large unilamellar vesicles (LUVs). In addition, switching from anionic SUVs to anionic LUVs suggests the lipid packing as a crucial factor for the interaction of protein and lipid. The monolayer model and the modulation of surface pressure aim to mimic the muscle at work (i.e. dynamic changes of muscle membrane during contraction and relaxation) (high and low surface pressure). Strikingly, the lateral pressure modifies the protein organization. Increasing the lateral pressure leads the proteins to be organized in a regular network. Nevertheless, a different protein conformation after its binding to monolayer is revealed by trypsin proteolysis. Label-free quantification by nano-LC/MS/MS allowed identification of the helices in repeats 12 and 13 involved in the interaction with anionic SUVs. These results, combined with our previous studies, indicate that DYS R11-15 constitutes the only part of dystrophin that interacts with anionic as well as zwitterionic lipids and adapts its interaction and organization depending on lipid packing and lipid nature. We provide strong experimental evidence for a physiological role of the central domain of dystrophin in sarcolemma scaffolding through modulation of lipid-protein interactions.

Indexed as

DystrophinGene Expression RegulationHumansLipidsLiposomesMicroscopy, Atomic ForceModels, MolecularMolecular ConformationPhospholipidsProtein Structure, SecondaryProtein Structure, TertiarySpectrinSurface PropertiesTrypsinDystrophinLipidsLiposomesPhospholipidsSpectrinTrypsin

Identifiers

PMID21712383
PMCPMC3162408
OpenAlexW2001473402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.